https://www.selleckchem.com/pr....oducts/Cryptotanshin
of ALAS. TRIAL REGISTRATION Clinical Research Information Service (cris.nih.go.kr), KCT0002257. Registered on 27 February 2017.BACKGROUND In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Health GmbH) against larval stages and immature adults of Aelurostrongylus abstrusus, as well as the treatment efficacy of a single or three monthly treatments against a
Like
Comment
Share
